These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21134980)

  • 1. Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma.
    Takeuchi K; Soda M; Togashi Y; Ota Y; Sekiguchi Y; Hatano S; Asaka R; Noguchi M; Mano H
    Haematologica; 2011 Mar; 96(3):464-7. PubMed ID: 21134980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 pathway is activated in ALK-positive large B-cell lymphoma carrying SQSTM1-ALK rearrangement and provides a possible therapeutic target.
    d'Amore ES; Visco C; Menin A; Famengo B; Bonvini P; Lazzari E
    Am J Surg Pathol; 2013 May; 37(5):780-6. PubMed ID: 23588372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification.
    Takeuchi K; Soda M; Togashi Y; Sugawara E; Hatano S; Asaka R; Okumura S; Nakagawa K; Mano H; Ishikawa Y
    Clin Cancer Res; 2011 May; 17(10):3341-8. PubMed ID: 21430068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion.
    Momose S; Tamaru J; Kishi H; Mikata I; Mori M; Toyozumi Y; Itoyama S
    Hum Pathol; 2009 Jan; 40(1):75-82. PubMed ID: 18755494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALK-positive diffuse large B-cell lymphoma: two more cases and a brief literature review.
    Rudzki Z; Rucińska M; Jurczak W; Skotnicki AB; Maramorosz-Kurianowicz M; Mruk A; Piróg K; Utych G; Bodzioch P; Srebro-Stariczyk M; Włodarska I; Stachura J
    Pol J Pathol; 2005; 56(1):37-45. PubMed ID: 15921012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas.
    Cerchietti L; Damm-Welk C; Vater I; Klapper W; Harder L; Pott C; Yang SN; Reiter A; Siebert R; Melnick A; Woessmann W
    PLoS One; 2011 Apr; 6(4):e18436. PubMed ID: 21494621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases.
    Gascoyne RD; Lamant L; Martin-Subero JI; Lestou VS; Harris NL; Müller-Hermelink HK; Seymour JF; Campbell LJ; Horsman DE; Auvigne I; Espinos E; Siebert R; Delsol G
    Blood; 2003 Oct; 102(7):2568-73. PubMed ID: 12763927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
    Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG
    Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetically complex SEC31A-ALK fusions are recurrent in ALK-positive large B-cell lymphomas.
    Bedwell C; Rowe D; Moulton D; Jones G; Bown N; Bacon CM
    Haematologica; 2011 Feb; 96(2):343-6. PubMed ID: 21109691
    [No Abstract]   [Full Text] [Related]  

  • 10. Anaplastic lymphoma kinase-positive large B-cell lymphoma: description of a case with an unexpected clinical outcome.
    Zanelli M; Valli R; Capodanno I; Ragazzi M; Ascani S
    Int J Surg Pathol; 2015 Feb; 23(1):78-83. PubMed ID: 24868005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel GORASP2-ALK fusion in an ALK-positive large B-cell lymphoma.
    Ise M; Kageyama H; Araki A; Itami M
    Leuk Lymphoma; 2019 Feb; 60(2):493-497. PubMed ID: 30187817
    [No Abstract]   [Full Text] [Related]  

  • 12. Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis.
    Ma Z; Cools J; Marynen P; Cui X; Siebert R; Gesk S; Schlegelberger B; Peeters B; De Wolf-Peeters C; Wlodarska I; Morris SW
    Blood; 2000 Mar; 95(6):2144-9. PubMed ID: 10706887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like).
    Touriol C; Greenland C; Lamant L; Pulford K; Bernard F; Rousset T; Mason DY; Delsol G
    Blood; 2000 May; 95(10):3204-7. PubMed ID: 10807789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.
    Sarris AH; Luthra R; Papadimitracopoulou V; Waasdorp M; Dimopoulos MA; McBride JA; Cabanillas F; Duvic M; Deisseroth A; Morris SW; Pugh WC
    Blood; 1996 Sep; 88(5):1771-9. PubMed ID: 8781434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC).
    Chikatsu N; Kojima H; Suzukawa K; Shinagawa A; Nagasawa T; Ozawa H; Yamashita Y; Mori N
    Mod Pathol; 2003 Aug; 16(8):828-32. PubMed ID: 12920229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target.
    Werner MT; Zhao C; Zhang Q; Wasik MA
    Blood; 2017 Feb; 129(7):823-831. PubMed ID: 27879258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel ALK fusion partners in lung cancer.
    Iyevleva AG; Raskin GA; Tiurin VI; Sokolenko AP; Mitiushkina NV; Aleksakhina SN; Garifullina AR; Strelkova TN; Merkulov VO; Ivantsov AO; Kuligina ESh; Pozharisski KM; Togo AV; Imyanitov EN
    Cancer Lett; 2015 Jun; 362(1):116-21. PubMed ID: 25813404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary anaplastic large cell lymphoma in the dura of the brain: case report and prediction of a favorable prognosis.
    Kim MK; Cho CH; Sung WJ; Ryoo HM; Lee HJ; Youn SW; Park KK
    Int J Clin Exp Pathol; 2013; 6(8):1643-51. PubMed ID: 23923083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor.
    Cools J; Wlodarska I; Somers R; Mentens N; Pedeutour F; Maes B; De Wolf-Peeters C; Pauwels P; Hagemeijer A; Marynen P
    Genes Chromosomes Cancer; 2002 Aug; 34(4):354-62. PubMed ID: 12112524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALK-positive large B-cell lymphoma (ALK + LBCL) with aberrant CD3 expression.
    Baker J; Zadeh SL; Aguilera NS
    J Hematop; 2024 Jun; 17(2):109-114. PubMed ID: 38573563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.